52 information-security "https:" "https:" "https:" "https:" "https:" "Dr" "Robert Gordon University" positions at Newcastle University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
PhD studentship in Trustworthy Multimodal AI under Lightweight and Data-Efficient Architectures Award Summary 100% fees covered, and a minimum tax-free annual living allowance of £20,780 (2025/26
-
England. Attracting and retaining high-calibre people is fundamental to our continued success. The role Newcastle Cancer Centre hosts one of Cancer Research UKs Clinical Academic Training Programmes
-
research training support grant £20,000 and 100% fees paid. Overview Climate change is driving more intense storms, putting drainage systems under pressure. Rain gardens (vegetated basins that manage
-
Award Summary This studentship provides a tax-free annual living allowance £26,546 plus a research training support grant £20,000 and 100% fees paid. Overview Climate change is driving more intense
-
duration: 4 years Sponsor: Newcastle University (NU Futures Fund) Supervisors: Dr Sarra Ryan, Dr Thomas Nicholls , Dr Robbie Bain Eligibility criteria: A 2:1 honours degree, or international equivalent, in
-
allowance of £21,805 (2026/27 UKRI rate), and a research training support grant of £20,000. Overview This PhD project is part of the CDT in Process Industries: Net Zero . Taylor–Couette technology exploits
-
Award summary 100% fees (UK home only), a minimum tax-free annual living allowance of £21,805 (2026/27 UKRI rate), and a research training support grant of £20,000. Overview This PhD project is part
-
field of multiphase flow modelling. Contact Dr Nadimi (sadegh.nadimi-shahraki@ncl.ac.uk) for more information. Number Of Awards 1 Start Date 1st October 2026 Award Duration 4 Years Application Closing
-
). Additional project costs will also be provided. Overview Additive manufacturing (3D printing) is a digital technology and a key enabler for realising next-generation equipment designs that are less energy
-
. Breast cancer is the most common malignancy in the UK, with over 55 000 new diagnoses annually. Surgery (lumpectomy or mastectomy) is the best line of treatment. To enable surgeons to identify the cancer